Systemic lupus erythematosus after acute lymphoblastic leukaemia

Systemic lupus erythematosus after acute lymphoblastic leukaemia.

Systemic lupus erythematosus after acute lymphoblastic leukaemia SIR, Systemic lupus erythematosus (SLE) is associated with an increased risk of neoplasia of the lympho-reticular system, particularly lymphoma [1, 2]. While non-Hodgkin's and Hodgkin's lymphomas are the commonest associated malignancies [3, 4], cases of myeloma [5, 6] and leukaemia [7] have also been documented and there have bee...

Neurobrucellosis in systemic lupus erythematosus

Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...

A Case of Systemic Lupus Erythematosus

SUMMARY During the course of systemic lupus erythematosus in a 10 year-old girl, a go it er develo ped. Subc linical I ly pothyrnic.Jism was found, in addition rising titer of ant imicrosomal antibody and overt hypothyroidism after 6-week cessation of thyroxin tablet lead to the diagnosis of Hashimoto's thyroiditis. Antibodies directed to the thyroid may result in an autoimmune thyroiditis in...

Hematologic manifestation of systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. The most common hematologic finding is anemia, leukopenia, thrombocytopenia and secondary antiphospholipid syndrome with recurrent abortion and thrombosis. The autoimmune fibrosis of bone marrow is another manifestation of autoimmune disease especially SLE, that must be correctly differentiated from primary myelofibrosis.

Systemic lupus erythematosus following acute lymphocytic leukemia.